Cargando…
The staging of sepsis: understanding heterogeneity in treatment efficacy
Human sepsis is an intrinsically complex disease. Populations of patients enrolled into clinical trials of novel sepsis therapies are notoriously heterogeneous with respect to the inciting cause of their disease, the co-morbid conditions that define its course, and the acute severity of their initia...
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1414009/ https://www.ncbi.nlm.nih.gov/pubmed/16356249 http://dx.doi.org/10.1186/cc3907 |